| Financial Year |
March 31 2023 |
| Monetary Funds |
232,325,480.70 |
| Held-for-trading Financial Assets |
267,111,686.22 |
| Notes Receivable |
152,000.00 |
| Accounts Receivable |
209,534,336.03 |
| Advances to Suppliers |
6,109,363.14 |
| Other Receivables |
2,540,194.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
147,070,462.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,809,352.90 |
| Total Current Assets |
930,953,752.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
248,821,152.94 |
| Under-construction Projects |
60,096,094.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,076,690.39 |
| R&D expenses |
-- |
| Goodwill |
103,983,861.22 |
| Long-Term Deferred and Prepaid Expenses |
5,351.93 |
| Deferred Income Tax Assets |
4,207,218.81 |
| Other Non-Current Assets |
7,908,721.50 |
| Sub-Total of Non-Current Assets |
477,915,658.98 |
| Total Assets |
1,408,869,411.00 |
| Short-Term Loans |
146,001,111.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,948,393.78 |
| Accounts Payable |
135,723,842.11 |
| Accounts Received In Advance |
114,864.99 |
| Employee Compensation Payable |
8,035,454.75 |
| Taxes Payable |
6,989,494.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,575,439.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
307,694.22 |
| Other Current Liabilities |
75,430.87 |
| Sub-Total of Current Liabilities |
365,155,715.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,261,058.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,053,667.15 |
| Total Liabilities |
375,209,382.97 |
| Paid-In Capital(Or Share Stock) |
178,516,800.00 |
| Capital Surplus |
373,034,101.55 |
| Surplus Reserve |
45,057,281.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
436,189,799.92 |
| Minority Stockholder's Interest |
894,520.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,032,765,507.82 |
| Owner's Equity（Stockholder's Equity） |
1,033,660,028.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,408,869,411.00 |
